<?xml version="1.0" encoding="utf-8" standalone="no"?>
<billStatus>
  <version>3.0.0</version>
  <bill>
    <number>6331</number>
    <updateDate>2023-01-11T13:21:30Z</updateDate>
    <updateDateIncludingText>2023-01-11T13:21:30Z</updateDateIncludingText>
    <originChamber>House</originChamber>
    <originChamberCode>H</originChamberCode>
    <type>HR</type>
    <introducedDate>2010-09-29</introducedDate>
    <congress>111</congress>
    <committees>
      <item>
        <systemCode>hsif00</systemCode>
        <name>Energy and Commerce Committee</name>
        <chamber>House</chamber>
        <type>Standing</type>
        <activities>
          <item>
            <name>Referred to</name>
            <date>2010-09-29T14:19:50Z</date>
          </item>
        </activities>
      </item>
    </committees>
    <actions>
      <item>
        <actionDate>2010-09-29</actionDate>
        <text>Referred to the House Committee on Energy and Commerce.</text>
        <type>IntroReferral</type>
        <actionCode>H11100</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hsif00</systemCode>
            <name>Energy and Commerce Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2010-09-29</actionDate>
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <actionCode>Intro-H</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2010-09-29</actionDate>
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <actionCode>1000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
    </actions>
    <sponsors>
      <item>
        <bioguideId>G000550</bioguideId>
        <fullName>Rep. Gingrey, Phil [R-GA-11]</fullName>
        <firstName>Phil</firstName>
        <lastName>Gingrey</lastName>
        <party>R</party>
        <state>GA</state>
        <district>11</district>
        <isByRequest>N</isByRequest>
      </item>
    </sponsors>
    <cosponsors>
      <item>
        <bioguideId>G000410</bioguideId>
        <fullName>Rep. Green, Gene [D-TX-29]</fullName>
        <firstName>GENE</firstName>
        <lastName>GREEN</lastName>
        <party>D</party>
        <state>TX</state>
        <district>29</district>
        <sponsorshipDate>2010-09-29</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>W000413</bioguideId>
        <fullName>Rep. Whitfield, Ed [R-KY-1]</fullName>
        <firstName>EDWARD</firstName>
        <lastName>WHITFIELD</lastName>
        <party>R</party>
        <state>KY</state>
        <district>1</district>
        <sponsorshipDate>2010-09-29</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>R000572</bioguideId>
        <fullName>Rep. Rogers, Mike J. [R-MI-8]</fullName>
        <firstName>Mike</firstName>
        <lastName>Rogers</lastName>
        <party>R</party>
        <state>MI</state>
        <district>8</district>
        <sponsorshipDate>2010-09-29</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>D000197</bioguideId>
        <fullName>Rep. DeGette, Diana [D-CO-1]</fullName>
        <firstName>DIANA</firstName>
        <lastName>DEGETTE</lastName>
        <party>D</party>
        <state>CO</state>
        <district>1</district>
        <sponsorshipDate>2010-09-29</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
    </cosponsors>
    <policyArea>
      <name>Health</name>
    </policyArea>
    <subjects>
      <legislativeSubjects>
        <item>
          <name>Administrative law and regulatory procedures</name>
        </item>
        <item>
          <name>Department of Health and Human Services</name>
        </item>
        <item>
          <name>Drug safety, medical device, and laboratory regulation</name>
        </item>
        <item>
          <name>Food and Drug Administration (FDA)</name>
        </item>
        <item>
          <name>Infectious and parasitic diseases</name>
        </item>
        <item>
          <name>Intellectual property</name>
        </item>
        <item>
          <name>Medical research</name>
        </item>
        <item>
          <name>Medical tests and diagnostic methods</name>
        </item>
        <item>
          <name>Prescription drugs</name>
        </item>
      </legislativeSubjects>
      <policyArea>
        <name>Health</name>
      </policyArea>
    </subjects>
    <summaries>
      <summary>
        <versionCode>00</versionCode>
        <actionDate>2010-09-29</actionDate>
        <actionDesc>Introduced in House</actionDesc>
        <updateDate>2011-01-26T14:55:36Z</updateDate>
        <text><![CDATA[ <p>Generating Antibiotic Incentives Now Act of 2010 - Amends the Federal Food, Drug, and Cosmetic Act to: (1) extend for five years&nbsp;the exclusivity period for the first licensure of a&nbsp;qualified infectious disease product; (2)&nbsp;grant priority review&nbsp;to&nbsp;an application for approval or licensure&nbsp;of&nbsp;a&nbsp;qualified infectious disease product (i.e., review and action on&nbsp;such application not later than six months after receipt); and (3) deem a qualified infectious disease product as a fast track product, for review and approval purposes.&nbsp; Defines "qualified infectious disease product" as an antibiotic drug, or a diagnostic test including a point-of-care diagnostic test, for treating, detecting, preventing, or identifying a qualifying pathogen.&nbsp; </p> <p>Requires the Secretary of Health and Human Services (HHS), acting through the Commissioner of Food and Drugs, to review the guidelines of the Food and Drug Administration (FDA) for the conduct of clinical trials for antibiotic drugs and revise such guidelines to reflect developments in medical information and technology.&nbsp; Allows the sponsor of a drug intended to be used to treat, detect, prevent, or identify a qualifying pathogen, as defined by this Act,&nbsp;to request that the Secretary provide written recommendations for nonclinical and clinical investigations before such drug may be approved for use or licensed.</p>]]></text>
      </summary>
    </summaries>
    <title>Generating Antibiotic Incentives Now Act of 2010</title>
    <titles>
      <item>
        <titleType>Display Title</titleType>
        <title>Generating Antibiotic Incentives Now Act of 2010</title>
      </item>
      <item>
        <titleType>Official Title as Introduced</titleType>
        <title>To provide incentives for the development of qualified infectious disease products.</title>
        <billTextVersionName>Introduced in House</billTextVersionName>
        <billTextVersionCode>IH</billTextVersionCode>
      </item>
      <item>
        <titleType>Short Titles as Introduced</titleType>
        <title>Generating Antibiotic Incentives Now Act of 2010</title>
      </item>
    </titles>
    <textVersions>
      <item>
        <type>Introduced in House</type>
        <date>2010-09-29T04:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-111hr6331ih/xml/BILLS-111hr6331ih.xml</url>
          </item>
        </formats>
      </item>
    </textVersions>
    <latestAction>
      <actionDate>2010-09-29</actionDate>
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </latestAction>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>
